BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30280773)

  • 1. Expression and prognosis of MYOZ2 in gastric cancer.
    Li YF; Zhu GY; Ma Y; Qu HY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5920-5927. PubMed ID: 30280773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
    Dong Y; Wang ZG; Chi TS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
    Zhang S; Xu J; Wang H; Guo H
    Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.
    Xu Y; Liu Z; Guo K
    Mol Cell Biochem; 2012 Apr; 363(1-2):93-9. PubMed ID: 22143536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
    Sun GG; Sheng SH; Jing SW; Hu WN
    Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
    World J Gastroenterol; 2016 Dec; 22(47):10364-10370. PubMed ID: 28058016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
    Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
    BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].
    Wang LP; Ma XQ; Cai JC
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3269-73. PubMed ID: 23328512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
    Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
    Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
    Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
    Qi H; Wang Y
    Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis.
    Myung E; Park YL; Kim N; Chung CY; Park HB; Park HC; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
    Pathol Res Pract; 2013 Nov; 209(11):692-9. PubMed ID: 24011795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
    Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
    Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
    Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
    Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.